2015
DOI: 10.1016/j.ymgme.2014.11.016
|View full text |Cite
|
Sign up to set email alerts
|

Mitochondrial Disease Sequence Data Resource (MSeqDR): A global grass-roots consortium to facilitate deposition, curation, annotation, and integrated analysis of genomic data for the mitochondrial disease clinical and research communities

Abstract: Success rates for genomic analyses of highly heterogeneous disorders can be greatly improved if a large cohort of patient data is assembled to enhance collective capabilities for accurate sequence variant annotation, analysis, and interpretation. Indeed, molecular diagnostics requires the establishment of robust data resources to enable data sharing that informs accurate understanding of genes, variants, and phenotypes. The “Mitochondrial Disease Sequence Data Resource (MSeqDR) Consortium” is a grass-roots eff… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
60
0
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
9

Relationship

5
4

Authors

Journals

citations
Cited by 80 publications
(61 citation statements)
references
References 21 publications
0
60
0
1
Order By: Relevance
“…Furthermore, both mitochondrial dysfunction and downregulation of PGC-1α are present in Huntington's disease, Alzheimer's disease, and Parkinson's disease, providing further support for a relationship between mitochondrial function and PGC-1α (Miraglia et al, 2015;Rice et al, 2015). Although a mitochondrial origin for these diseases has been proposed (Falk et al, 2015), regulation of mitochondrial biogenesis in the context of these diseases has not been extensively studied. In this study, we established cell lines in which PGC-1α was overexpressed or knocked down to investigate the signaling pathways by which PGC-1α could influence cell growth.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, both mitochondrial dysfunction and downregulation of PGC-1α are present in Huntington's disease, Alzheimer's disease, and Parkinson's disease, providing further support for a relationship between mitochondrial function and PGC-1α (Miraglia et al, 2015;Rice et al, 2015). Although a mitochondrial origin for these diseases has been proposed (Falk et al, 2015), regulation of mitochondrial biogenesis in the context of these diseases has not been extensively studied. In this study, we established cell lines in which PGC-1α was overexpressed or knocked down to investigate the signaling pathways by which PGC-1α could influence cell growth.…”
Section: Discussionmentioning
confidence: 99%
“…These studies are possible because mtDNA is transmitted as a nonrecombining unit through maternal lineages, provides an exceptional record of mutations over time (Ingman et al 2000;Meyer et al 1999;Tamura 2000), and is present in numerous copies in each cell, and because databases of entire human mtDNA sequences are readily available for comparison (Falk et al 2015;Shokolenko and Alexeyev 2015).…”
Section: Background Mitochondrial Dnamentioning
confidence: 99%
“…These “canonical criteria” are as follows: (1) the mutation is not a known neutral polymorphism; (2) the mutation must be in an evolutionarily conserved site, suggesting a functional role for the SNP; (3) the mutation is usually heteroplasmic; (4) for heteroplasmic variants, the degree of heteroplasmy should correlate clinically with a phenotype; and (5) the mutation can be corroborated biochemically using tissue samples (initially described with muscle biopsy). With respect to determining whether a particular variant is novel or not, several databases exist, including dbSNP [25], MITOMAP [26], mtDB [27], PhyloTree [28] and MSeqDR [29]. We currently refer to mtDB and MSeqDR for most applications.…”
Section: Mitochondrial Geneticsmentioning
confidence: 99%